In October 2024, a team of Chinese researchers at Peking University reported that a 25-year-old woman who had lived with Type 1 diabetes since childhood stopped needing insulin injections within 75 days of receiving an experimental stem cell transplant ge
A Chinese stem‑cell transplant reportedly freed a young Type 1 diabetic from insulin in just 75 days.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
In October 2024 a team at Peking University reported that a 25‑year‑old woman with lifelong Type 1 diabetes stopped needing insulin injections within 75 days after receiving an experimental stem‑cell transplant. Coverage highlights the case as a sign of potential progress.
Rockdale Citizen and KGUN 9 note that a clinical trial is expanding, while Diabetes In Control discusses whether stem‑cell therapy could change care for the disease. The Spokesman‑Review features reader responses, and Space Daily repeats the original October 2024 report.
Future reporting will focus on whether additional participants achieve similar outcomes, how regulators respond, and what next‑phase trial data emerge, according to the outlets tracking the story.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 56d ago.
Quick answers
What outcome was reported for the patient in the Peking University study?
The patient reportedly stopped needing insulin injections within 75 days of the stem‑cell transplant.
Which media outlets are covering the potential of stem‑cell therapy for Type 1 diabetes?
Rockdale Citizen, KGUN 9, Diabetes In Control, The Spokesman‑Review and Space Daily are all publishing related coverage.
What is the next step mentioned in the coverage regarding the therapy?
Reports indicate that a clinical trial is expanding to include more participants.
Coverage (5)
- ASK THE DOCTORS: Type 1 Diabetes Clinical Trial Expanding Rockdale Citizen · 56d ago
- Type one diabetes trial shows promising results in islet cell transplants KGUN 9 · 56d ago
- Could Stem Cell Therapy Change Type 1 Diabetes Forever? Preparing for the Next Era of Care Diabetes In Control · 56d ago
- Ask the doctors: Readers respond The Spokesman-Review · 56d ago
- In October 2024, a team of Chinese researchers at Peking University reported that a 25-year-old woman who had lived with Type 1 diabetes since childhood stopped needing insulin injections within 75 days of receiving an experimental stem cell transplant ge Space Daily · 56d ago
Topics
Related trends
Nvidia employee charged with smuggling advanced chips into China
Employees from Nvidia and Supermicro face charges for the illegal export of advanced AI servers to China.
China is the biggest buyer of Iran’s oil. Could US sanctions threaten those ties?
China's position as the primary purchaser of Iranian oil faces potential instability amid renewed economic threats from the Trump administration.
China robot maker Unitree's post-listing slump sparks bubble fears
Unitree's stock decline following a massive surge has triggered concerns over a potential bubble in the robotics sector.
Is my kimchi safe? China formaldehyde cabbage scandal puts Korea on alert
A food safety crisis has emerged as China investigates the illegal use of formaldehyde to preserve napa cabbage, triggering alerts in South Korea.
Japan lawmakers visit China seeking to ease tensions over Taiwan
A cross-party delegation of Japanese lawmakers has traveled to China in an effort to mend diplomatic ties and ease tensions regarding Taiwan.
Humanoid robot soldiers likely only 5-10 years away, one developer behind China's robotics boom tells CBS News
1 news sources are covering this Sports story right now — PULSE is tracking how fast it spreads.